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CONCLUSIONS: Temporal bone chondroblastomas are extremely rare and aggressive, 
but the outcome after appropriate surgical treatment is favorable.  From the review, it 
may be particularly important to deal with tumors that involve the temporomandibular 
joint (TMJ), which could affect the long term outcomes, as well as tumor recurrence. 
OBJECTIVE: To report a case of chondroblastoma and to review their presentation. 
BACKGROUND: Chondroblastomas are highly destructive tumors that are derived 
from immature cartilage cells.  The occurrence of this tumor in the temporal bone or 
skull base is uncommon.  Approximately 70 cases have previously been reported, 
several of which have involved the TMJ. 
CASE DESCRIPTION: We currently report the case of a 67-year-old woman who 
presented with right-sided mixed hearing loss, a right external auditory canal mass, ear 
fullness, otalgia, bloodstained otorrhea, and pain around TMJ, associated with difficulty 
in opening the mouth.  CT and MRI revealed a mass involving the TMJ, infratemporal 
fossa, and pterygopalatine fossa.  The patient underwent tumor resection via an 
infratemporal fossa approach type B.  Gross total tumor removal was achieved, with 
no facial nerve paralysis or other complications observed after surgery.  No recurrence 







 Chondroblastomas are rare benign bone tumors that represent approximately 
1% of all primary bone tumors.  Most of these tumors commonly arise in the epiphysis 
of the long bones, and tumors of the temporal bones are extremely rare [1].  A 
chondroblastoma of the temporal bone was first reported by Denko and Krauel in 1955, 
and since then, around 70 cases have been reported [2-4].  We report a case of 
chondroblastoma of the temporal bone, and review the literature to discuss the clinical 




 In February 2003, a 67-year-old woman presented to our institute with a 5 
month history of Right sided hearing loss.  She also complained of tinnitus, otalgia, 
bloodstained otorrhea and temporomandibular joint (TMJ) pain on movement.  
However, she had no dizziness, facial palsy or other cranial nerve involvement.  Upon 
otoscopic examination, there was a mass noted in the external auditory canal.  The 
mass almost totally occluded the lumen of the external auditory canal, and the lesion 
allowed for only a limited view of the postero inferior part of the tympanic membrane 
(Figure 1).  An audiogram showed a 56.7 dB mixed hearing loss with a 31.7 dB 
air-bone gap in the right ear. 
 A CT scan showed a solid, dense mass with diffuse calcification.  The 
expansive growth had invaded the external auditory canal and extended into the middle 
ear with bony erosion (Fig. 2A).  It also extended medial to the TMJ, anteriorly to the 
pterygopalatine fossa, and superiorly to erode the bony floor of the middle cranial fossa 
(Fig. 2B, 2C).  The tumor had a non-homogenous appearance and low intensity on T1 
weighted MRI and showed iso to high intensity on T2 weighted MRI.  The tumor had 
invaded TMJ capsule and middle cranial fossa superiorly (Fig. 3).  The internal carotid 
artery was not involved. 
 The patient underwent resection via an infratemporal approach type B in March 
2003.  A cranio-temporal incision was performed and the external auditory canal was 
transected and closed.  The extra temporal facial nerve was exposed in the parotid and 
a subtotal petrosectomy was performed.  The tumor had involved the antero medial 
part of the bony external auditory canal and occupied the mesotypanum and anterior 
attic.  Additionally, the tumor had invaded the middle cranial fossa dura and involved 
the glenoid fossa but spared the condyle.  The skin of the bony external auditory canal, 
the tympanic membrane, the malleus, and the incus were removed after disarticulation 
of the incudostapedial joint.  The facial nerve was skeletonized and the inner ear was 
preserved, while the vertical portion of the internal carotid artery was identified and 
skeletonized.  The capsule of the TMJ was detached and removed but since the 
condyle was not involved, it was left in place.  The middle meningeal artery and the 
mandibular nerve were coagulated and cut, and the bony eustachian tube was drilled out, 
identifying the horizontal part of the carotid artery.  Although the tumor was adherent 
to the middle cranial fossa dura, it was easily detached and was removed completely.  
Lastly the eustachian tube was closed and the operative defect obliterated with 
abdominal fat.   
 The patient had an uneventful postoperative period without any signs of facial 
palsy after surgery or any other complications, and was discharged 3 days later.  The 
resected tumor showed histological findings consistent with chondroblastoma.  Her 1 
year follow up CT revealed that the surgical defect was obliterated with adipose tissue 





 Chondroblastomas typically occur in the long bone epiphyses of children, and 
are uncommon in patients over 25 years of age [5, 6].  Chondroblastoms involving the 
temporal bones are uncommon, and only 70 cases have been reported, with only 45 
having detailed pathologic and clinical treatment data.  The common location of a 
temporal bone chondroblastoma is at the squamous portion, due to its cartilaginous 
origin [7, 8].  The tumor is also anatomically attached to the TMJ region and 
presumably originates from the TMJ articular hyaline cartilage [9].  The characteristic 
growth pattern of the tumor may result from embryonal cartilaginous rests entrapped in 
the tympanosquamous suture line in the temporal bone.  The suture is anterosuperior to 
the external auditory canal and anatomically very close to TMJ [10].  Most patients 
with temporal bone chondroblastomas were older than those with tumors at the usual 
site, the ages ranged from 8 years to 85 years old, with a mean of 39.4 [4, 11].  Of the 
45 patients, 20 were male and 25 were female, and there was a variety of symptoms.  
34 patients (76%) presented with otologic complaints, including hearing loss, tinnitus, 
otalgia, otorrhea and vertigo, and 12 patients (27%) complained of a temporal mass or 
swelling, whereas 11 patients (24%) presented with difficulties of mastication and TMJ 
symptoms [3, 4, 8, 12].  In terms of neurological complaints, 6 patients (13%) 
presented with headache or seizures, 7 patients (16%) presented with facial palsy, and 1 
patient presented with a lower cranial nerve dysfunction [4].  The duration of 
symptoms was known in 41 cases, and ranged from 20 days to 10 years, with a mean of 
15 months [13].  Our patient was symptomatic for 5 months, and was older than the 
mean age that has been reported.  The patient exhibited the typical symptoms of 
chondroblastoma including hearing loss, tinnitus, otalgia, otorrhea and pain on TMJ 
movement.  Compared to the mean length of follow-up (3.6 years) from 36 cases, our 
patient was followed up for a relatively long period of seven and a half years after 
surgery [4, 14]. 
 
Radiological findings 
 Radiologically, temporal bone chondroblastomas are solid or cystic masses that 
are characterized as osteolytic lesions, sometimes with spotty calcification.  
Calcification within the lesion has been documented in 20 to 50% of cases and can be 
identified well with CT [4, 6, 11, 15, 16].  However, although diffuse calcification 
patterns are uncommon, our case displayed calcification in almost the entire tumor 
unlike the CT findings of previously reported cases of temporal bone chondroblastoma.    
The appearance of chondroblastomas is variable in MRI and various patterns of 
enhancement, either peripheral, homogenous or heterogenous, have been seen with the 
use of gadolinium [4, 17].  There is usually low intensity on T1 images, and low to 




 On the basis of clinical and radiographic examination results, malignant lesions 
such as chondrosarcoma, osteosarcoma, malignant fibrohistocytoma as well as benign 
osseus tumors such as giant cell tumor, osteoma and fibrous dysphasia must be 
considered.  A chondroblastoma is composed primarily of immature chondroblasts 
with focal ‘‘chicken-wire’’ calcification, multinucleated giant cells, polygonal cells and 
acidophilic cytoplasm with the chondroid matrix [7, 8].  Immunoreactivity to S-100 
has  been  widely  used  to  assist  in  the  differentiation  of  chondroblastomas 
from  other  pathological identities as S-100 positivity is present in 90% of 
chondroblastomas, and only 13% of giant cell tumors [18]. 
 
Surgical Treatment 
 Complete surgical resection is the standard procedure for the treatment of a 
temporal bone chondroblastoma.  It has been reported that approximately 50% of 
patients with temporal bone chondroblastomas who were treated with curettage 
developed recurrent disease, requiring a secondary procedure, while the overall 
recurrence rate after total tumor removal is about 20%, according to the published 
literature [6, 7, 19, 20].  Bertoni et al. reviewed the published literature and found that 
TMJ extension was seen in 2 out of 21 patients (10%) [20].  In the published literature, 
we found that 16 out of the 45 patients (36%) had tumor invasion into the TMJ, and 5 
out of 9 patients (56%) had TMJ involvement of the tumor in recurrent or residual cases 
(Table 1) [3-5, 7, 10, 12-17, 19].  The involvement of the TMJ and petrous bone is 
common in recurrent or residual cases.  Several cases of temporal bone 
chondroblastomas need additional treatment or radiation therapy (because of recurrence 
or residual tumor). [4, 6, 14] 
   Because of the close anatomical relationship of a chondroblatoma to vital 
neurovascular structures, aggressive attempts to completely remove the tumor without 
adequate exposure would be hazardous.  Since chondroblastomas usually arise from 
the anterior temporal bone near the TMJ, adequate exposure of the TMJ is essential.  A 
high recurrence rate of temporal bone chondroblastoma has been previously reported 
when using the via middle cranial fossa approach [3, 6].  Kurokawa et al. reported that 
surgical treatment of the tumors via a transzygomatic approach with mandibular 
condyle removal and exposure through the middle fossa approach is not adequate for 
removing temporal bone chondroblastomas.  On the other hand, an infratemporal 
fossa approach provides adequate exposure for large tumors involving the TMJ.  
Infratemporal fossa approach type B is extralabyrinthine approach which is designed 
mainly for extra dural lesions involving the petrous apex and clivus including the 
horizontal segment of the internal carotid artery (Fig. 5).  The posterior infratemporal 
fossa is accessible but the pterygoid process remains intact.  Inftratemporal fossa 
approach type C is an anterior extension of the infratemporal fossa approach type B, in 
which the pterygoid process is drilled, and is used for exposure of the infratemporal 
fossa, pterygopalatine fossa, parasellar region, and nasopharynx.  Both infratemporal 
fossa approaches provide good control of the TMJ.  Some recent publications reported 
that excellent outcomes for temporal bone chondroblastomas can be achieved by 
preserving the TMJ or mandibular condyle through the infratemporal fossa approach [4, 
13].  The key to the successful treatment of a temporal bone chondroblastoma might be 
the surgical management of the tumor obscured by the glenoid fossa and TMJ which 
can be accessed via an infratemporal fossa approach as our report. 
 
Conclusion 
 We present a case of a patient with a chondroblastoma of the temporal bone 
and review the previously-published literature.  A chondroblastoma of the temporal 
bone is an uncommon tumor, but the outcome after appropriate surgical treatment is 
quite favorable, and it is our opinion that proper access is necessary to deal with tumors 
involving the temporomandibular joint, which could be related to the long term outcome 
of the patient, as well as tumor recurrence. 
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Table 1  Summary of temporal bone chondroblastoma cases: tumor invasion into 
temporomandibular joint (from the literature). 
 Sex Age Symptoms Site of Tumor Treatment 
Anim and 
Bakara, 1986 
m 55 HL, Painful Swelling, 
Otorrhea 
TMJ, Posterior End of Zygoma Trans Mastoid 
Tanohata et al., 
1986 
f 55 HL, Tinnitus, Otalgia, 
Headache 
Anterior to TMJ, Squamous, MF Resection 
Horn et al., 1990 m 34 HL, Painful Swelling Replaced Glenoid Fossa Trans Mastoid and 
MFA 
Politi et al., 1991 m 53 Swelling Glenoid Cavity, Squamous Curettage 
Varvares et al., 
1992 
m 33 HL, Otalgia, Headache, TMJ 
Dysfunction 
EAC, Petrous, TMJ Trans Mastoid and 
Cervical 
Leong et al., 1994 m 23 Ear Fullness on Mastication Anterior to TMJ, MF Trans Mastoid 
Selesnick and 
Lenine, 1999 
f 30 Otalgia, TMJ syndrome, 
Trismus 
Lateral and Medial to Condyle, 
MF 
Zygomatic, MFA 
Watanabe et al., 
1999 
f 43 HL, Ear Fullness Superior and Anterior to TMJ, 
Posterior Zygomatic Root, 
Squamous, MF 
Trans Mastoid 
Ishikawa et al., 
2002 
m 24 Arthralgia of TMJ, Painful 
Swelling, Difficulty of 
Mouth Opening 
Pterygoid Fossa, TMJ, MF Dura Zygomatic 
Pontius et al., 
2003 
m 38 Otalgia, Otorrhea EAC, TMJ, Petrous, Squamous MFA, Trans Mastoid 
Kurokawa et al., 
2005 
f 32 HL, Tinnitus, Limitation of 
Mouth Opening 
Mandibular Fossa, Zygomatic 
Root, Middle Ear 
Zygomatic 
 m 27 HL, Tinnitus, Pain of TMJ Mandibular Fossa , Zygomatic 
Arch 
Zygomatic 
Cabrera et al., 
2006 
f 38 Parotid Mass TMJ, Parotid Gland Excision 
Kutz et al., 2007 f 62 HL, Otalgia, Ear Fullness Condyle, Middle Ear, MF ITFA 
 f 39 Otalgia, Headache, Facial 
Palsy 
Anterior to Condyle ITFA 
Moon et al., 2008 f 48 HL, Facial Palsy, Trismus Sphenoid bone, Carotid Canal, 
Condyle, Inner Ear 
ITFA 
 





